Walter Scott & Partners Limited – Trademark Portfolio

Entity Type: 11

Walter Scott & Partners Limited holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 36 (Insurance & Financial) — 9 filings in this category. Currently, 6 trademarks are registered. Notable registered marks include NCS, NCS GLOBAL FUND, NCS GROUP TRUST, NCS INTERNATIONAL FUND, and NCS INSTITUTIONAL FUND LIMITED. The owner is based in Edinburgh.

One Charlotte Square

Edinburgh EH24DR , GB

9 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Walter Scott & Partners Limited's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

36
Insurance & Financial (9 filings)

Insurance; financial affairs; monetary affairs; real estate affairs

Frequently Asked Questions

How many trademarks does Walter Scott & Partners Limited have?

Walter Scott & Partners Limited has 9 U.S. trademarks filed with the USPTO. Of these, 6 registered, 1 abandoned, 2 cancelled.

What trademark classes does Walter Scott & Partners Limited file in?

Walter Scott & Partners Limited files trademarks across 1 Nice Classification class. The most active classes are Class 36 (Insurance & Financial). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.

What are Walter Scott & Partners Limited's most well-known trademarks?

Walter Scott & Partners Limited's registered trademark portfolio includes well-known marks such as NCS, NCS GLOBAL FUND, NCS GROUP TRUST, NCS INTERNATIONAL FUND, and NCS INSTITUTIONAL FUND LIMITED. These are among 6 currently registered trademarks in the portfolio.

What is Walter Scott & Partners Limited's trademark registration success rate?

Walter Scott & Partners Limited has a 67% trademark registration rate, with 6 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.